Pacira | PCRX - Current Assets


Pacira reported $615.21M in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Astellas Pharma JPY 1.49T 63.68B Jun/2026
Bristol-Myers Squibb USD 28.58B 1.37B Jun/2026
Cara Therapeutics USD 25.33M 6.21M Mar/2026
Coherus Biosciences USD 133.79M 72.25M Jun/2026
Heron Therapeutics USD 228.98M 9.08M Mar/2026
Ironwood Pharmaceuticals USD 332.29M 58.11M Mar/2026
J&J USD 59.77B 601M Jun/2026
Ligand Pharmaceuticals USD 865.42M 33.14M Mar/2026
Nektar Therapeutics USD 589.04M 322.77M Mar/2026
Novo Nordisk DKK 208.7B 31.38B Jun/2026
Omeros USD 69.65M 26.53M Jun/2025
Pacira USD 615.21M 100.25M Jun/2026
Perrigo USD 2.45B 260.7M Jun/2026
Pfizer USD 41.36B 1.46B Jun/2026
Supernus Pharmaceuticals USD 723.5M 8.08M Jun/2026
Teva Pharmaceutical Industries USD 13.76B 50M Jun/2026
Xeris Pharmaceuticals USD 251.68M 11.37M Mar/2026
Zoetis USD 6.47B 294M Mar/2026